Nadia Tarhini: Evaluating the Risk of Recurrent Thrombosis in Children with ALL
Nadia Tarhini, Clinical Research Assistant at Boston Children’s Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Thrombosis Research, adding:
“I’m excited to announce my first co-authorship on a research publication!
I’m incredibly grateful for the opportunity to contribute to this project and gain a more in-depth knowledge about venous thrombo-embolisms among pediatric patients with acute lymphoblastic leukemia.
A special thank you to Dr. Riten Kumar on the opportunity to work collaboratively on this project and Dr. Olivia Perrone and Dr. Lynda Vrooman for their ongoing support and guidance throughout BCH/DFCI’s contribution on this project!”
Riten Kumar, Director of Thrombosis and Anticoagulation at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, reposted Nadia Tarhini’s post on LinkedIn:
“Was great to collaborate with Dr Pelland-Marcotte on this multicenter study evaluating the risk of recurrent thrombosis in children with ALL.
Notably, the risk of recurrence remains substantial, with most patients experiencing recurrent thrombosis early during treatment.
These findings underscore the need for better predictors of thrombus progression and recurrence in children with cancer associated thrombosis.”
Title: Clinical outcomes following catheter-related venous thrombo-embolism among children with acute lymphoblastic leukemia
Authors: Marie-Claude Pelland-Marcotte, Thai Hoa Tran, Chantal Éthier, Camille Beaulieu, Thien Vu Truong, Olivia Perrone, Nadia Tarhini, Juliann Duzan, Lynda M. Vrooman, Melissa Burns, Lewis B. Silverman, Riten Kumar

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering